AVICENNA PHARMACY AS
1362 HOSLE
Return on Equity
100,79Â %
Current Ratio
1,8
Debt-to-Equity Ratio
2,6
| Key figures (NOK) | 2022 | |
|---|---|---|
| Revenue | 11Â 595Â 000 | |
| Net Income | 767Â 000 | |
| Total Assets | 4Â 888Â 000 | |
| Total Equity | 761Â 000 |
| Income (NOK) | 2022 | |
|---|---|---|
| Revenue | 11Â 595Â 000 | |
| Expenditure | 10Â 526Â 000 | |
| Operating Profit | 1Â 069Â 000 | |
| Financial Income | 0 | |
| Financial Costs | 86Â 000 | |
| Financial Balance | −86 000 | |
| Earnings Before Tax | 983Â 000 | |
| Tax | 216Â 000 | |
| Net Income | 767Â 000 |
| Balance (NOK) | 2022 | |
|---|---|---|
| Total Fixed Assets | 1Â 022Â 000 | |
| Total Current Assets | 3Â 866Â 000 | |
| Total Assets | 4Â 888Â 000 | |
| Total Retained Equity | 706Â 000 | |
| Total Equity | 761Â 000 | |
| Total Long-Term Debt | 1Â 979Â 000 | |
| Total Current Debt | 2Â 148Â 000 | |
| Total Equity and Debt | 4Â 888Â 000 |
| Cash flow (NOK) | 2022 | |
|---|---|---|
| Sales Income | 11Â 595Â 000 | |
| Other Income | 0 | |
| Revenue | 11Â 595Â 000 | |
| Cost of Goods Sold | 8Â 447Â 000 | |
| Salary Costs | 1Â 408Â 000 | |
| Depreciation | 67Â 000 | |
| Impairment | 0 | |
| Expenditure | 10Â 526Â 000 | |
| Operating Profit | 1Â 069Â 000 | |
| Financial Income | 0 | |
| Financial Costs | 86Â 000 | |
| Financial Balance | −86 000 | |
| Dividends | 0 | |
| Net Income | 767Â 000 |
| Balance details (NOK) | 2022 | |
|---|---|---|
| Goodwill | 0 | |
| Total Intangible Assets | 0 | |
| Real Eastate | 0 | |
| Machinery and Plant Facilities | 0 | |
| Fixtures | 420Â 000 | |
| Total Tangible Assets | 420Â 000 | |
| Total Fiancial Fixed Assets | 602Â 000 | |
| Total Fixed Assets | 1Â 022Â 000 | |
| Stock | 1Â 210Â 000 | |
| Total Investments | 0 | |
| Cash, Bank | 2Â 606Â 000 | |
| Total Current Assets | 3Â 866Â 000 | |
| Total Assets | 4Â 888Â 000 | |
| Total Equity | 761Â 000 | |
| Short-Term Group Debt | 0 | |
| Total Long-Term Debt | 1Â 979Â 000 | |
| Creditors | 1Â 608Â 000 | |
| Unpaid Taxes | 219Â 000 | |
| Dividends | 0 | |
| Other Current Debt | 147Â 000 | |
| Total Current Debt | 2Â 148Â 000 | |
| Total Equity and Debt | 4Â 888Â 000 |
| Financial indicators | 2022 | |
|---|---|---|
| Return on Equity | 100,79Â % | |
| Debt-to-Equity Ratio | 2,6 | |
| Operating Profit Margin | 9,22Â % | |
| Current Ratio | 1,8 | |
| Quick Ratio | 4,12 | |
| Equity Ratio | 0,16 | |
| Gross Profit Margin | 27,15Â % |
Rotate your device to see the full table